Steward Partners Investment Advisory, LLC Sarepta Therapeutics, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $11 Billion
- Q4 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 312 shares of SRPT stock, worth $18,985. This represents 0.0% of its overall portfolio holdings.
Number of Shares
312
Previous 118
164.41%
Holding current value
$18,985
Previous $14,000
164.29%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding SRPT
# of Institutions
521Shares Held
85.9MCall Options Held
1.55MPut Options Held
1.37M-
Black Rock Inc. New York, NY10.3MShares$628 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$553 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$529 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$263 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$248 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $5.33B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...